MedTrace Logo

Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome

NCT01562002 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2015-01-08

No results posted yet for this study

Summary

The purpose of the study is to determine whether allogenic bone marrow stem cell transplant is safe and effective in the treatment of limbus insufficiency syndrome versus allogenic limbus stem cell transplant.

Conditions

  • Limbus Corneae Insufficiency Syndrome

Interventions

PROCEDURE

Stem Cell with Amniotic Membrane Transplant

Single stem cell expansion in amniotic membrane transplant

Sponsors & Collaborators

  • University of Valladolid

    collaborator OTHER

  • Centro en Red de Medicina Regenerativa de Castilla y Leon

    collaborator OTHER

  • Red de Terapia Celular

    collaborator INDUSTRY

  • Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

    lead OTHER

Principal Investigators

  • Margarita Calonge, MD, PhD · Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01562002 on ClinicalTrials.gov